High-throughput Drug Discovery
At Greenstone Biosciences, we combine the power of human iPSC biology with state-of-the-art automation and data-rich screening technologies to revolutionize drug discovery. Our high-throughput platforms are designed to rapidly evaluate thousands of compounds across diverse human cell models, providing deep insights into efficacy, toxicity, and mechanism of action. This approach accelerates the identification of promising therapeutic candidates and reduces reliance on non-human models, delivering more predictive insights into human biology.
Rapid, Scalable Screening for Smarter Decisions
Our high-throughput screening platform enables researchers to:
- Quickly assess the impact of compounds on disease-relevant cell types.
- Identify potential toxicity signals early, reducing late-stage failures.
- Capture complex biological responses using advanced functional and multi-omics readouts.
By leveraging automation and standardized protocols, we generate reproducible, high-quality data at scale. This allows scientists to make informed decisions faster, focus resources on the most promising leads, and streamline the path from discovery to preclinical development.
A Platform to Accelerate Therapeutic Discovery
Greenstone’s high-throughput platform supports a broad spectrum of research applications:
By integrating human iPSC models with large-scale screening capabilities, our platform creates a direct link between cellular biology and therapeutic potential—enabling more predictive, efficient, and patient-relevant drug discovery.
Expertise and Partnership
We don’t just provide high-throughput screening services; we partner with researchers and pharmaceutical teams to design experiments that maximize insight and impact. Our team’s expertise in stem cell biology, pharmacology, and translational science ensures that every screen is executed with precision and interpreted with scientific rigor.
Transforming Drug Discovery for Patients
Greenstone’s high-throughput iPSC platforms are helping to redefine the drug discovery process. By enabling faster, smarter, and more human-relevant screens, we empower researchers to uncover breakthrough therapies and bring them closer to the patients who need them most.
Discover Patient-Relevant Insights
Leverage automation, iPSC biology, and predictive data to uncover breakthrough therapies faster.